In addition it addresses the FDA’s communications with the applicant, the retention of data that guidance the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer possession of the SE report to a new applicant and Digital submission of the SE report and amendments.